ING Group’s Avanos Medical AVNS Stock Holding History

ING Group’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-7,282	Closed	-$318K	–	497
2019 Q2	$318K	Buy	7,282 +10	+0.1%	+$428	0.01%	644
2019 Q1	$310K	Buy	7,272 +2	+0%	+$90	0.01%	593
2018 Q4	$326K	Buy	+7,270	New	+$381K	0.01%	565
2018 Q3	–	Sell	-7,202	Closed	-$412K	–	775
2018 Q2	$412K	Buy	7,202 +65	+0.9%	+$3.44K	0.01%	518
2018 Q1	$329K	Buy	7,137 +77	+1%	+$3.66K	0.01%	589
2017 Q4	$326K	Buy	7,060 +1,329	+23%	+$61.1K	0.01%	623
2017 Q3	$258K	Buy	5,731 +54	+1%	+$2.3K	0.01%	742
2017 Q2	$223K	Buy	+5,677	New	+$215K	﹤0.01%	770
2016 Q2	–	Sell	-12,577	Closed	-$361K	–	527
2016 Q1	$361K	Hold	12,577	–	–	﹤0.01%	425
2015 Q4	$420K	Buy	+12,577	New	+$391K	﹤0.01%	579

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

ING Group's AVNS Position: Q3 2019 in Review

ING Group sold out of Avanos Medical (AVNS) in Q3 2019, closing a stake of 7,282 shares — an estimated $318K sold.

ING Group first reported a position in AVNS in Q4 2015 and held it in 10 quarters. The position peaked at $420K in Q4 2015. 290 funds tracked by Wall St. Rank hold AVNS as of Q3 2019.

ING Group reported no remaining Avanos Medical position as of Q3 2019 after selling out during the quarter.
ING Group sold 7,282 Avanos Medical shares in Q3 2019, an estimated $318K.
ING Group first reported a position in Avanos Medical in Q4 2015 and held it in 10 quarters.
ING Group's Avanos Medical position peaked at $420K in Q4 2015.
290 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2019.

Based on ING Group's 13F filing for Q3 2019, filed 8 Nov 2019.